Second primary cancers in survivors of childhood cancer

The Lancet

Volumn 374, Issue 9700, 2009, Pages 1484-1485

  Oeffinger, Kevin C ^a   Bhatia, Smita ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER SCREENING; CANCER SURVIVOR; CHILDHOOD CANCER; DISEASE ASSOCIATION; DISEASE COURSE; DNA POLYMORPHISM; HIGH RISK POPULATION; HUMAN; MORBIDITY; MORTALITY; MYELODYSPLASTIC SYNDROME; PEDIATRICS; PRIORITY JOURNAL; SECOND CANCER;

EID: 70449109460     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)61885-7     Document Type: Note

References (16)

1. Olsen J.H., Moller T., Anderson H., et al. Lifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries. J Natl Cancer Inst 101 (2009) 806-813
2. Neglia J.P., Friedman D.L., Yasui Y., et al. Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J Natl Cancer Inst 93 (2001) 618-629
3. Jenkinson H.C., Hawkins M.M., Stiller C.A., Winter D.L., Marsden H.B., and Stevens M.C. Long-term population-based risks of second malignant neoplasms after childhood cancer in Britain. Br J Cancer 91 (2004) 1905-1910
4. Bhatia S., and Sklar C. Second cancers in survivors of childhood cancer. Nat Rev Cancer 2 (2002) 124-132
5. Evans W.E., and McLeod H.L. Pharmacogenomics-drug disposition, drug targets, and side effects. N Engl J Med 348 (2003) 538-549
6. Berwick M., and Vineis P. Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J Natl Cancer Inst 92 (2000) 874-897
7. Mertens A.C., Liu Q., Neglia J.P., et al. Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst 100 (2008) 1368-1379
8. Oeffinger K.C., Mertens A.C., Sklar C.A., et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 355 (2006) 1572-1582
9. Landier W., Bhatia S., Eshelman D.A., et al. Development of risk-based guidelines for pediatric cancer survivors: the Children's Oncology Group long-term follow-up guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline. J Clin Oncol 22 (2004) 4979-4990
10. Scottish Intercollegiate Guidelines Network (SIGN). Long term follow up of survivors of childhood cancer: a national clinical guideline (January, 2004). http://www.sign.ac.uk/pdf/sign76.pdf (accessed July 7, 2009).
11. United Kingdom Children's Cancer Study Group Late Effects Group. Therapy based long-term follow up: a practice statement (April, 2005). http://www.cclg.org.uk/researchandtreatment/content.php?3id=29&2id=1 9 (accessed July 7, 2009).
12. Kremer L.C.M., Jaspers M.W.M., van Leeuwen F.E., et al. National guidelines for the follow-up of childhood cancer survivors. Tijdschr Kindergeneeskunde 6 (2006) 214-218 (in Dutch).
13. Meadows A.T., Friedman D.L., Neglia J.P., et al. Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort. J Clin Oncol 27 (2009) 2356-2362
14. Begg C.B., Haile R.W., Borg A., et al. Variation of breast cancer risk among BRCA1/2 carriers. JAMA 299 (2008) 194-201
15. Oeffinger K.C., Ford J.S., Moskowitz C.S., et al. Breast cancer surveillance practices among women previously treated with chest radiation for a childhood cancer. JAMA 301 (2009) 404-414
16. National Cancer Institute. About risk prediction models. http://riskfactor.cancer.gov/cancer_risk_prediction/about.html (accessed July 7, 2009).